We can't find the internet
Attempting to reconnect
13766.3 PFLS-LS
13766.3 PFLS-LS
Résumé
Erythrocyte-binding Uricase for Inducing Immunological Tolerance
Textes supplémentaires
Abstract
A protein engineering technology will be developed for induction of antigen-specific immunological tolerance,|applicable for tolerance to protein drugs and to autoimmunity antigens. In this project, the technology will be|developed in the context of reducing the unwanted immunogenicity reactions towards the therapeutic protein|drug uricase (urate oxidase, Rasburicase), by engineering tolerogenic forms of uricase and thus enabling|safe treatment of tumor lysis syndrome and gout.
Participants
Oscar Buset
Wirtschaftspartner
oscar@anokion.com
Anokion SA Oscar Buset Chemin des Condémines 22 B 1028 Préverenges VD CH
Jeffrey Hubbell
Kontaktperson
jeffrey.hubbell@epfl.ch
EPFL SV IBI LMRP Jeffrey Hubbell Station 15 1015 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2013-04-30
- Date de fin
- 2015-10-31
- Coûts totaux approuvés
- CHF 559523.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%